The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Bär & Karrer Ltd.

BRANDSCHENKESTRASSE 90, 8027 ZÜRICH, SWITZERLAND
Tel:
Work +41 58 261 50 00
Fax:
Fax +41 58 261 50 01
Email:
Web:
www.baerkarrer.ch
Geneva, Lugano, Zug, Zurich

Saverio Lembo

Tel:
Work +41 58 261 57 00
Email:
Web:
www.baerkarrer.ch/lawyers/partner/lembo-saverio.html
Bär & Karrer Ltd.

Work Department

Litigation | White Collar Crime | Arbitration | Reorganization & Insolvency | Media, Entertainment & Sports | Internal Investigation | Employment

Position

Saverio Lembo heads Bär & Karrer's White Collar Crime practice group.

He has extensive experience in white collar crime, commercial and financial litigation, international judicial assistance (civil and criminal), arbitration and insolvency. During recent years, he has been involved in a number of complex commercial litigation proceedings, has served as a party representative or arbitrator in various domestic and international commercial arbitrations and has assisted clients in Swiss and foreign criminal proceedings. He regularly represents clients before the Court of Arbitration for Sport (CAS).

Saverio Lembo's practice also extends to pharmaceutical litigation, inheritance law, employment matters and enforcement of foreign judgments and awards.

Saverio Lembo is ranked in tier 1 of the leading lawyers in White-Collar Crime Switzerland by Chambers & Partners. He was awarded "Lawyer of the Year 2016" in the categories Criminal Defense and Litigation in the Geneva area by Best Lawyers. Since 2012, the International Who's Who lists him among the world's leading practitioners in the areas of Business Crime Defense, Asset Recovery Lawyers and Commercial Litigation. In The Legal 500, Saverio Lembo has been listed among the leading individuals in Switzerland in Dispute Resolution since 2010.

Career

  • Partner of Bär & Karrer (since 2003)
  • Associate at Bär & Karrer (2000)
  • Secondment at Slaughter and May, London (1997)
  • Associate at a Swiss law firm (1995)

Languages

French, Italian, English, German

Member

Regional Representative Europe of the IBA Criminal Law Committee (since 2019)

  • Co-Chair of the International Anti-Money Laundering Committee, American Bar Association SIL (since 2017)
  • Vice-Chair of the International Arbitration Committee, American Bar Association SIL (2014-2016)
  • Co-Chair of the International Criminal Law Committee, American Bar Association SIL (2012-2014)
  • Co-Chair of AIJA Human Rights Committee (2011)
  • Lecturer at the "Ecole d'Avocature", University of Geneva, Criminal Law Proceedings (since 2011)
  • President of the Association Internationale des Jeunes Avocats (AIJA) (2009-2010)
  • President of the Commercial Fraud Commission of AIJA (2006-2008)
  • Member of the Executive Committee of the Associazione Internazionale dei Giuristi di Lingua Italiana (AIGLI) (1998-2008)
  • International Bar Association (IBA)
  • Member of (ASA) Association Suisse de l'Arbitrage
  • Geneva Bar Association (OdA)
  • Association Genevoise du Droit des Affaires (AGDA)
  • Société Suisse de droit pénal
  • Member of the Committee of the Geneva Young Lawyers Bar (1994-1995)

Education

  • Admitted to the Geneva Bar (Ranked 1st, 1995)
  • University of Geneva: lic. iur. (1992)
  • University of Geneva: lic. oec. (1989)


Switzerland

Dispute resolution: arbitration

Within: Dispute resolution: arbitration

The multilingual team at Bär & Karrer Ltd. has 'excellent knowledge of Swiss law', focusing on M&A, private client, intellectual property and IT disputes for a range of companies in the scientific, automotive, media and technology industries. Pierre-Yves Gunter serves as chairman in a $700m ICC arbitration proceeding concerning the Panama canal, and also co-represents the National Iranian Gas Company in a €5bn gas dispute against claimant Turkmengas. Daniel Hochstrasser in Zurich and the 'terrific' Geneva-based Saverio Lembo, who 'has excellent practical judgement', are also key partners.

[back to top]

Dispute resolution: litigation

Within: Leading individuals

Saverio Lembo - Bär & Karrer Ltd.

Within: Dispute resolution: litigation

Full-service firm Bär & Karrer Ltd. stands out for its 'in-depth know-how and pragmatic legal advice', as well as its 'experience in complex international cases and good relationships with other relevant entities'. The ten-partner team is best known for M&A, private client, intellectual property, IT litigation and white-collar criminal law matters. In a pending matter before the Swiss Supreme Court, Pierre-Yves Gunter and Aurélie Conrad Hari are instructed by Omea to enforce an award against the Republic of Equatorial Guinea in order to secure a payment of more than €95m, while Matthew T Reiter represented an industrial company in a successful appeal proceeding before the Zurich Superior Court concerning profit margins related to a share purchase agreement. 'Excellent outside-the-box thinkerAndreas Länzlinger acts for an insurance carrier as respondent to the insured in a proceeding regarding alleged claims under a professional indemnity insurance policy. Saverio Lembo is a key partner in Geneva.

[back to top]

Leading firms: French-speaking Switzerland

Within: Leading firms: French-speaking Switzerland

Bär & Karrer Ltd.'s team impresses with its 'straight-to-the-point advice, great availability and efficiency'. Its practice groups are uniquely strong in handling transactions, as well as banking, regulatory, dispute resolution and white-collar criminal law matters. Cédric Chapuis, Saverio Lembo, Pierre-Yves Gunter and 'skilled arbitrator' Alexandra Johnson are the names to note. The Geneva office was further bolstered by the arrivals of Martin Anderson and Frederic Betrisey from Baker McKenzie.

[back to top]


Back to index

Legal Developments by:
Bär & Karrer Ltd.

  • Bär & Karrer Advises Swedish Orphan Biovitrum AB in the Acquisition of emapalumab

    Swedish Orphan Biovitrum AB, an international specialty biopharmaceutical company listed in Sweden, agreed to acquire, from Novimmune’s shareholders, a newly established company owning emapalumab and related assets, giving Sobi access to world-class R&D capabilities in the field of Immunology. The acquisition supersedes the previously announced exclusive licence agreement with Novimmune. In addition, Sobi agreed with Novimmune on options for the shared financial rights to NI-1701 and NI-1801, two product candidates in the field of immuno-oncology. The transaction value is CHF 515 million, of which CHF 400 million was previously committed in the exclusive license agreement for emapalumab.
    - BÄR & KARRER LTD.

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to